查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1178011

近視及老花眼治療市場:各類型(矯正，外科，投藥)，各地區(2022年～2032年)

Myopia and Presbyopia Treatment Market by Type (Corrective, Surgical, Drugs), and by Region - 2022 to 2032
出版日期: | 出版商: Transparency Market Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球近視及老花眼治療市場相關調查，提供市場概要，以及2022年～2031年的預測，各類型，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 市場背景

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 趨勢
  • 情勢預測
  • 機會地圖分析
  • 產品生命週期分析
  • 投資可行性矩陣
  • PESTLE和波特分析
  • 法規情形
  • 各地區父母市場預測

第4章 全球近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)

  • 過去的市場規模(100萬美元)分析，2017年～2021年
  • 現在及未來市場規模(100萬美元)的預測，2022年～2032年

第5章 全球近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各類型

  • 簡介/主要調查結果
  • 過去的市場規模(100萬美元)分析，2017年～2021年，各類型
  • 現在及未來市場規模(100萬美元)的預測，2022年～2032年，各類型
    • 矯正
    • 外科
    • 投藥
  • 前一年同期比較成長傾向分析，各類型，2017年～2021年
  • 機會分析，各類型，2022年～2032年

第6章 全球近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各地區

  • 簡介
  • 過去的市場規模(100萬美元)分析，2017年～2021年，各地區
  • 現在及未來市場規模(100萬美元)的預測，2022年～2032年，各地區
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲
  • 市場魅力分析，各地區

第7章 北美的近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各國

第8章 raten'ameri的近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各國

第9章 歐洲的近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各國

第10章 亞太地區的近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各國

第11章 中東·非洲的近視及老花眼治療市場分析(2017年～2021年)及預測(2022年～2032年)，各國

第12章 主要國家的近視及老花眼治療市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列

第13章 市場結構分析

第14章 競爭分析

  • 競爭詳細內容
    • Ziemer Ophthalmic Systems AG
    • NIDEK CO., LTD.
    • Johnson &Johnson Vision
    • Essilor Ltd.
    • Zeiss International
    • ALCON VISION LLC
    • Bausch &Lomb Incorporated.
    • Carl Zeiss AG
    • Orasis Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.
    • Haag-Streit UK
    • Topcon Corporation
    • AbbVie
    • Sydnexis
    • The Cooper Companies Inc

第15章 假設和縮寫的使用

第16章 調查手法

Product Code: TMRGL84780

TMR's report on the global myopia and presbyopia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global myopia and presbyopia treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global myopia and presbyopia treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the myopia and presbyopia treatment market.

The report delves into the competitive landscape of the global myopia and presbyopia treatment market. Key players operating in the global myopia and presbyopia treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global myopia and presbyopia treatment market profiled in this report.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Investment Feasibility Matrix
  • 3.6. PESTLE and Porter's Analysis
  • 3.7. Regulatory Landscape
    • 3.7.1. By Key Regions
    • 3.7.2. By Key Countries
  • 3.8. Regional Parent Market Outlook

4. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast, 2022-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Myopia Treatment Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Myopia Treatment Type, 2017-2021
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Myopia Treatment Type, 2022-2032
    • 5.3.1. Corrective
      • 5.3.1.1. Prescription Lenses
      • 5.3.1.2. Contact Lenses
      • 5.3.1.3. Intraocular Lenses
    • 5.3.2. Surgical
    • 5.3.3. Drugs
  • 5.4. Y-o-Y Growth Trend Analysis By Myopia Treatment Type, 2017-2021
  • 5.5. Absolute $ Opportunity Analysis By Myopia Treatment Type, 2022-2032

6. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region

  • 6.1. Introduction
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
  • 6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
    • 6.3.1. North America
    • 6.3.2. Latin America
    • 6.3.3. Europe
    • 6.3.4. Asia Pacific
    • 6.3.5. Middle East and Africa
  • 6.4. Market Attractiveness Analysis By Region

7. North America Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 7.2.1. By Country
      • 7.2.1.1. U.S.
      • 7.2.1.2. Canada
    • 7.2.2. By Myopia Treatment Type
  • 7.3. Market Attractiveness Analysis
    • 7.3.1. By Country
    • 7.3.2. By Myopia Treatment Type
  • 7.4. Key Takeaways

8. Latin America Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 8.2.1. By Country
      • 8.2.1.1. Brazil
      • 8.2.1.2. Mexico
      • 8.2.1.3. Rest of Latin America
    • 8.2.2. By Myopia Treatment Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Myopia Treatment Type
  • 8.4. Key Takeaways

9. Europe Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 9.2.1. By Country
      • 9.2.1.1. Germany
      • 9.2.1.2. U.K.
      • 9.2.1.3. France
      • 9.2.1.4. Spain
      • 9.2.1.5. Italy
      • 9.2.1.6. Russia
      • 9.2.1.7. Rest of Europe
    • 9.2.2. By Myopia Treatment Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Myopia Treatment Type
  • 9.4. Key Takeaways

10. Asia Pacific Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 10.2.1. By Country
      • 10.2.1.1. China
      • 10.2.1.2. Japan
      • 10.2.1.3. India
      • 10.2.1.4. South Korea
      • 10.2.1.5. Australia
      • 10.2.1.6. Rest of APAC
    • 10.2.2. By Myopia Treatment Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Myopia Treatment Type
  • 10.4. Key Takeaways

11. Middle East and Africa Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    • 11.2.1. By Country
      • 11.2.1.1. South Africa
      • 11.2.1.2. Saudi Arabia
      • 11.2.1.3. UAE
      • 11.2.1.4. Israel
      • 11.2.1.5. Rest of MEA
    • 11.2.2. By Myopia Treatment Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Myopia Treatment Type
  • 11.4. Key Takeaways

12. Key Countries Myopia and Presbyopia Treatment Market Analysis

  • 12.1. U.S.
    • 12.1.1. Pricing Analysis
    • 12.1.2. Market Share Analysis, 2021
      • 12.1.2.1. By Myopia Treatment Type
  • 12.2. Canada
    • 12.2.1. Pricing Analysis
    • 12.2.2. Market Share Analysis, 2021
      • 12.2.2.1. By Myopia Treatment Type
  • 12.3. Brazil
    • 12.3.1. Pricing Analysis
    • 12.3.2. Market Share Analysis, 2021
      • 12.3.2.1. By Myopia Treatment Type
  • 12.4. Mexico
    • 12.4.1. Pricing Analysis
    • 12.4.2. Market Share Analysis, 2021
      • 12.4.2.1. By Myopia Treatment Type
  • 12.5. Germany
    • 12.5.1. Pricing Analysis
    • 12.5.2. Market Share Analysis, 2021
      • 12.5.2.1. By Myopia Treatment Type
  • 12.6. U.K.
    • 12.6.1. Pricing Analysis
    • 12.6.2. Market Share Analysis, 2021
      • 12.6.2.1. By Myopia Treatment Type
  • 12.7. France
    • 12.7.1. Pricing Analysis
    • 12.7.2. Market Share Analysis, 2021
      • 12.7.2.1. By Myopia Treatment Type
  • 12.8. Spain
    • 12.8.1. Pricing Analysis
    • 12.8.2. Market Share Analysis, 2021
      • 12.8.2.1. By Myopia Treatment Type
  • 12.9. Italy
    • 12.9.1. Pricing Analysis
    • 12.9.2. Market Share Analysis, 2021
      • 12.9.2.1. By Myopia Treatment Type
  • 12.10. Russia
    • 12.10.1. Pricing Analysis
    • 12.10.2. Market Share Analysis, 2021
      • 12.10.2.1. By Myopia Treatment Type
  • 12.11. China
    • 12.11.1. Pricing Analysis
    • 12.11.2. Market Share Analysis, 2021
      • 12.11.2.1. By Myopia Treatment Type
  • 12.12. Japan
    • 12.12.1. Pricing Analysis
    • 12.12.2. Market Share Analysis, 2021
      • 12.12.2.1. By Myopia Treatment Type
  • 12.13. India
    • 12.13.1. Pricing Analysis
    • 12.13.2. Market Share Analysis, 2021
      • 12.13.2.1. By Myopia Treatment Type
  • 12.14. South Korea
    • 12.14.1. Pricing Analysis
    • 12.14.2. Market Share Analysis, 2021
      • 12.14.2.1. By Myopia Treatment Type
  • 12.15. Australia
    • 12.15.1. Pricing Analysis
    • 12.15.2. Market Share Analysis, 2021
      • 12.15.2.1. By Myopia Treatment Type
  • 12.16. South Africa
    • 12.16.1. Pricing Analysis
    • 12.16.2. Market Share Analysis, 2021
      • 12.16.2.1. By Myopia Treatment Type
  • 12.17. Saudi Arabia
    • 12.17.1. Pricing Analysis
    • 12.17.2. Market Share Analysis, 2021
      • 12.17.2.1. By Myopia Treatment Type
  • 12.18. UAE
    • 12.18.1. Pricing Analysis
    • 12.18.2. Market Share Analysis, 2021
      • 12.18.2.1. By Myopia Treatment Type
  • 12.19. Israel
    • 12.19.1. Pricing Analysis
    • 12.19.2. Market Share Analysis, 2021
      • 12.19.2.1. By Myopia Treatment Type

13. Market Structure Analysis

  • 13.1. Competition Dashboard
  • 13.2. Competition Benchmarking
  • 13.3. Market Share Analysis of Top Players
    • 13.3.1. By Regional
    • 13.3.2. By Myopia Treatment Type

14. Competition Analysis

  • 14.1. Competition Deep Dive
    • 14.1.1. Ziemer Ophthalmic Systems AG
      • 14.1.1.1. Overview
      • 14.1.1.2. Product Portfolio
      • 14.1.1.3. Profitability by Market Segments
      • 14.1.1.4. Sales Footprint
      • 14.1.1.5. Strategy Overview
        • 14.1.1.5.1. Marketing Strategy
    • 14.1.2. NIDEK CO., LTD.
      • 14.1.2.1. Overview
      • 14.1.2.2. Product Portfolio
      • 14.1.2.3. Profitability by Market Segments
      • 14.1.2.4. Sales Footprint
      • 14.1.2.5. Strategy Overview
        • 14.1.2.5.1. Marketing Strategy
    • 14.1.3. Johnson & Johnson Vision
      • 14.1.3.1. Overview
      • 14.1.3.2. Product Portfolio
      • 14.1.3.3. Profitability by Market Segments
      • 14.1.3.4. Sales Footprint
      • 14.1.3.5. Strategy Overview
        • 14.1.3.5.1. Marketing Strategy
    • 14.1.4. Essilor Ltd.
      • 14.1.4.1. Overview
      • 14.1.4.2. Product Portfolio
      • 14.1.4.3. Profitability by Market Segments
      • 14.1.4.4. Sales Footprint
      • 14.1.4.5. Strategy Overview
        • 14.1.4.5.1. Marketing Strategy
    • 14.1.5. Zeiss International
      • 14.1.5.1. Overview
      • 14.1.5.2. Product Portfolio
      • 14.1.5.3. Profitability by Market Segments
      • 14.1.5.4. Sales Footprint
      • 14.1.5.5. Strategy Overview
        • 14.1.5.5.1. Marketing Strategy
    • 14.1.6. ALCON VISION LLC
      • 14.1.6.1. Overview
      • 14.1.6.2. Product Portfolio
      • 14.1.6.3. Profitability by Market Segments
      • 14.1.6.4. Sales Footprint
      • 14.1.6.5. Strategy Overview
        • 14.1.6.5.1. Marketing Strategy
    • 14.1.7. Bausch & Lomb Incorporated.
      • 14.1.7.1. Overview
      • 14.1.7.2. Product Portfolio
      • 14.1.7.3. Profitability by Market Segments
      • 14.1.7.4. Sales Footprint
      • 14.1.7.5. Strategy Overview
        • 14.1.7.5.1. Marketing Strategy
    • 14.1.8. Carl Zeiss AG
      • 14.1.8.1. Overview
      • 14.1.8.2. Product Portfolio
      • 14.1.8.3. Profitability by Market Segments
      • 14.1.8.4. Sales Footprint
      • 14.1.8.5. Strategy Overview
        • 14.1.8.5.1. Marketing Strategy
    • 14.1.9. Orasis Pharmaceuticals
      • 14.1.9.1. Overview
      • 14.1.9.2. Product Portfolio
      • 14.1.9.3. Profitability by Market Segments
      • 14.1.9.4. Sales Footprint
      • 14.1.9.5. Strategy Overview
        • 14.1.9.5.1. Marketing Strategy
    • 14.1.10. Regeneron Pharmaceuticals Inc.
      • 14.1.10.1. Overview
      • 14.1.10.2. Product Portfolio
      • 14.1.10.3. Profitability by Market Segments
      • 14.1.10.4. Sales Footprint
      • 14.1.10.5. Strategy Overview
        • 14.1.10.5.1. Marketing Strategy
    • 14.1.11. Haag-Streit UK
      • 14.1.11.1. Overview
      • 14.1.11.2. Product Portfolio
      • 14.1.11.3. Profitability by Market Segments
      • 14.1.11.4. Sales Footprint
      • 14.1.11.5. Strategy Overview
        • 14.1.11.5.1. Marketing Strategy
    • 14.1.12. Topcon Corporation
      • 14.1.12.1. Overview
      • 14.1.12.2. Product Portfolio
      • 14.1.12.3. Profitability by Market Segments
      • 14.1.12.4. Sales Footprint
      • 14.1.12.5. Strategy Overview
        • 14.1.12.5.1. Marketing Strategy
    • 14.1.13. AbbVie
      • 14.1.13.1. Overview
      • 14.1.13.2. Product Portfolio
      • 14.1.13.3. Profitability by Market Segments
      • 14.1.13.4. Sales Footprint
      • 14.1.13.5. Strategy Overview
        • 14.1.13.5.1. Marketing Strategy
    • 14.1.14. Sydnexis
      • 14.1.14.1. Overview
      • 14.1.14.2. Product Portfolio
      • 14.1.14.3. Profitability by Market Segments
      • 14.1.14.4. Sales Footprint
      • 14.1.14.5. Strategy Overview
        • 14.1.14.5.1. Marketing Strategy
    • 14.1.15. The Cooper Companies Inc
      • 14.1.15.1. Overview
      • 14.1.15.2. Product Portfolio
      • 14.1.15.3. Profitability by Market Segments
      • 14.1.15.4. Sales Footprint
      • 14.1.15.5. Strategy Overview
        • 14.1.15.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

List of Tables

  • Table 1: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032
  • Table 2: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
  • Table 3: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 4: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
  • Table 5: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 6: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
  • Table 7: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 8: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
  • Table 9: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 10: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
  • Table 11: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
  • Table 12: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032

List of Figures

  • Figure 1: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 2: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) by Region, 2022-2032
  • Figure 3: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032
  • Figure 4: Global Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032
  • Figure 5: Global Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032
  • Figure 6: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 7: Global Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 8: Global Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 9: Global Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 10: Global Myopia and Presbyopia Treatment Market Attractiveness by Region, 2022-2032
  • Figure 11: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 12: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
  • Figure 13: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 14: North America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 15: North America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 16: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 17: North America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 18: North America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 19: North America Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 20: North America Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
  • Figure 21: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 22: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
  • Figure 23: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 24: Latin America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 25: Latin America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 26: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 27: Latin America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 28: Latin America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 29: Latin America Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 30: Latin America Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
  • Figure 31: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 32: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
  • Figure 33: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 34: Europe Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 35: Europe Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 36: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 37: Europe Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 38: Europe Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 39: Europe Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 40: Europe Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
  • Figure 41: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 42: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
  • Figure 43: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 44: Asia Pacific Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 45: Asia Pacific Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 46: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 47: Asia Pacific Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 48: Asia Pacific Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 49: Asia Pacific Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 50: Asia Pacific Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
  • Figure 51: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
  • Figure 52: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
  • Figure 53: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 54: Middle East and Africa Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
  • Figure 55: Middle East and Africa Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
  • Figure 56: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
  • Figure 57: Middle East and Africa Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
  • Figure 58: Middle East and Africa Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
  • Figure 59: Middle East and Africa Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
  • Figure 60: Middle East and Africa Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032